The medical cannabis market is set to witness noteworthy growth in the coming years, particularly in North America and Europe. The adoption of medical cannabis is set to scale new heights predominantly driven by legislative amendments that have played an important role in the decriminalization of cannabis consumption.
In addition, these legislative changes have also led to a significant rise in cannabis production for therapeutic and medical purposes. The rise in demand for medical cannabis is largely backed by research activities and scientific advancements that offer valuable insights related to the potential benefits of medical cannabis to treat an array of diseases.
The growth of the medical cannabis market is likely to be primarily driven by a combination of political, social, and economic interests during the forecast period. At present, around 30 nations have legalized the therapeutic application of medical cannabis and cannabis extracts and as per the current trends, the number is set to grow over the assessment period– a factor that is set to boost the growth of the market for medical cannabis during the forecast period.
The projected growth in the number of countries that are expected to decriminalize cannabis for medical purposes and the rise in the number of research activities pertaining to the potential benefits of medical cannabis are some of the leading factors that are expected to drive the growth of the market, which is projected to reach a value of US$ 52.8 Bn by the end of 2027.
To know the scope of our report Get a Sample on Medical Cannabis Market
Over the past decade, clinical research activities coupled with the evolving legal framework in various nations of Europe and North America have laid the foundation for the medical cannabis market growth. Research activities have played a key role in improving awareness regarding the link between cannabinoids and human physiology.
Moreover, while medical cannabis is projected to attract significant investments during the assessment period, it is likely to open up significant job opportunities in the STEM space. In recent times, research and development activities are increasingly focusing on investigating the physiology and biology of cannabinoids and an array of other bioactive compounds extracted from cannabis.
Get a glimpse of the in-depth analysis through our Report Brochure
Although the medical cannabis market is at a nascent stage, clinical research activities are anticipated to gain notable momentum in the upcoming years. In addition, as per the analysts at Transparency Market Research, collaborations between botanists, biologists, organic chemists, medical doctors, and pharmacologists, along with experts in therapeutic product design, drug formulation, and clinical trial space will play a key role in the development of the market during the assessment period.
Some of the most post-promising benefits of medical cannabis include minimizing pain, and nausea, and easing the different symptoms of Parkinson’s disease. Furthermore, a considerable amount of research is being carried out to evaluate the potential benefits and applications of medical cannabis to treat a myriad of skin conditions and mental health issues, including anxiety and PTSD.
Consumption of medical cannabis is set to witness unprecedented growth in the U.S., Canada, and several nations across the European Union. As per the current trends, medical cannabis is on the course of becoming one of the most prominent new consumer segments in the U.S. Some of the major factors that are likely to augment the consumption of medical cannabis is the shift in tide among consumers toward plant-based therapies, growing preference for natural alternatives over prescription drugs, and significant development in the wellness as a lifestyle space.
Due to the onset of the COVID-19 pandemic, analysts at the International Monetary Fund and the United Nations have projected that a global recession is on the cards. However, amidst the economic crisis, government authorities around the world could legalize the use of medical cannabis to create recession-proof jobs. While legalizing the use of medical cannabis is largely possible, research and development activities are expected to grow in the coming months aiming to unlock the complete potential of medical cannabis to treat different diseases.
The consumption patterns of medical cannabis are expected to show a slight decline during the second quarter of 2020; consumption of medical cannabis particularly for medical applications is expected to grow. One of the major challenges that would require significant attention in the medical cannabis market would be streamlining the supply lines.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global medical cannabis market is set to grow at a staggering CAGR of 27% during the forecast period. The market growth can be primarily attributed to a host of factors, including legislative changes across different countries wherein decriminalization of cannabis and products derived from cannabis has played an important role.
In addition, as governments across North America and Europe continue to regulate the production of medical cannabis, the demand for the same is expected to grow at a rapid pace. Research and development activities are anticipated to open up new applications of medical cannabis to treat a host of medical diseases in the coming years.
Medical Cannabis Market – Segmentation
The report analyzes the global market for medical cannabis based on derivative, application, route of administration, distribution channel, and region. Key segments under each criterion have been studied at length and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global medical cannabis industry.
|
Derivative |
|
|
Application |
|
|
Route of Administration |
|
|
Distribution Channel |
|
|
Region |
|
It was worth US$ 8 Bn and is projected to reach a value of US$ 52.8 Bn by the end of 2027
It is anticipated to grow at a CAGR of 27% during the forecast period
North America accounted for a major share of the global market
Global market for Medical cannabis driven by projected growth in the number of countries that are expected to decriminalize cannabis for medical purposes and rise in the number of research activities pertaining to the potential benefits of medical cannabis are some of the leading factors that are expected to drive the market
Canopy Growth Corporation, United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald Health Therapeutics, GW Pharmaceuticals plc, Tilray, Medical Marijuana, Inc., The Supreme Cannabis Company, Inc., and The Cronos Group
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Medical Cannabis Market: Market Snapshot
4. Market Overview
4.1. Global Medical Cannabis Market: Type Overview
4.2. Global Medical Cannabis Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.6. Restraints
4.7. Opportunities
4.8. Global Medical Cannabis Market Revenue Projections (US$ Mn), 2017–2027
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Overview of Legal Medical Marijuana in the U.S. States
5.3. Regulatory Scenario Assessment
5.4. Review of Medical Cannabis Clinical Trials
5.5. Top 3 players operating in the market
6. Global Medical Cannabis Market Analysis, by Derivative
6.1. Introduction
6.2. Global Medical Cannabis Market Value and Forecast, by Derivative
6.2.1. Tetrahydrocannabinol (THC)
6.2.2. Cannabidiol (CBD)
6.2.3. Others
6.3. Global Medical Cannabis Market Analysis, by Derivative
6.4. Global Medical Cannabis Market Attractiveness Analysis, by Derivative
7. Global Medical Cannabis Market Analysis, by Application
7.1. Introduction
7.2. Global Medical Cannabis Market Value and Forecast, by Application
7.2.1. Mental Health Management
7.2.1.1. Anxiety
7.2.1.2. Depression
7.2.1.3. Others
7.2.2. Neurological Disorders Management
7.2.2.1. Epilepsy
7.2.2.2. Alzheimer’s Disease
7.2.2.3. Parkinson’s Disease
7.2.2.4. Others
7.2.3. Pain Management
7.2.3.1. Neuropathic Pain
7.2.3.2. Cancer Pain
7.2.3.3. Others
7.3. Global Medical Cannabis Market Analysis, by Application
7.4. Global Medical Cannabis Market Attractiveness Analysis, by Application
8. Global Medical Cannabis Market Analysis, by Route of Administration
8.1. Introduction
8.2. Global Medical Cannabis Market Value and Forecast, by Route of Administration
8.2.1. Nasal
8.2.2. Oral
8.2.3. Others
8.3. Global Medical Cannabis Market Analysis, by Route of Administration
8.4. Global Medical Cannabis Market Attractiveness Analysis, by Route of Administration
9. Global Medical Cannabis Market Analysis, by Distribution Channel
9.1. Introduction
9.2. Global Medical Cannabis Market Value and Forecast, by Distribution Channel
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Global Medical Cannabis Market Analysis, by Distribution Channel
10. Global Medical Cannabis Market Attractiveness Analysis, by Distribution Channel
11. Global Medical Cannabis Market Analysis, by Region
11.1. Global Medical Cannabis Market Value and Forecast, by Region, 2017–2027
11.1.1. North America
11.1.2. Europe
11.1.3. Latin America
11.1.4. Rest of the World
11.2. Global Medical Cannabis Market Analysis, by Region
11.3. Global Medical Cannabis Market Attractiveness Analysis, by Region
12. North America Medical Cannabis Market Analysis
12.1. North America Medical Cannabis Market
12.2. North America Medical Cannabis Market Overview
12.3. North America Medical Cannabis Market Value and Forecast, by Derivative
12.3.1. Tetrahydrocannabinol (THC)
12.3.2. Cannabidiol (CBD)
12.3.3. Others
12.4. North America Medical Cannabis Market Value and Forecast, by Application
12.4.1. Mental Health Management
12.4.1.1. Anxiety
12.4.1.2. Depression
12.4.1.3. Others
12.4.2. Neurological Disorders Management
12.4.2.1. Epilepsy
12.4.2.2. Alzheimer’s Disease
12.4.2.3. Parkinson’s Disease
12.4.2.4. Others
12.4.3. Pain Management
12.4.3.1. Neuropathic Pain
12.4.3.2. Cancer Pain
12.4.3.3. Others
12.5. North America Medical Cannabis Market Value and Forecast, by Route of Administration
12.5.1. Nasal
12.5.2. Oral
12.5.3. Others
12.6. North America Medical Cannabis Market Value and Forecast, by Distribution Channel
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.7. North America Medical Cannabis Market Forecast, by Country
12.7.1. U.S.
12.7.2. Canada
12.8. North America Medical Cannabis Market Attractiveness Analysis
12.8.1. By Derivative
12.8.2. By Application
12.8.3. By Route of Administration
12.8.4. By Distribution Channel
12.8.5. By Country
13. Europe Medical Cannabis Market Analysis
13.1. Europe Medical Cannabis Market
13.2. Europe Medical Cannabis Market Overview
13.3. Europe Medical Cannabis Market Value and Forecast, by Derivative
13.3.1. Tetrahydrocannabinol (THC)
13.3.2. Cannabidiol (CBD)
13.3.3. Others
13.4. Europe Medical Cannabis Market Value and Forecast, by Application
13.4.1. Mental Health Management
13.4.1.1. Anxiety
13.4.1.2. Depression
13.4.1.3. Others
13.4.2. Neurological Disorders Management
13.4.2.1. Epilepsy
13.4.2.2. Alzheimer’s Disease
13.4.2.3. Parkinson’s Disease
13.4.2.4. Others
13.4.3. Pain Management
13.4.3.1. Neuropathic Pain
13.4.3.2. Cancer Pain
13.4.3.3. Others
13.5. Europe Medical Cannabis Market Value and Forecast, by Route of Administration
13.5.1. Nasal
13.5.2. Oral
13.5.3. Others
13.6. Europe Medical Cannabis Market Value and Forecast, by Distribution Channel
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.7. Europe Medical Cannabis Market Forecast, by Country/Sub-region
13.7.1. U.K.
13.7.2. France
13.7.3. Germany
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Europe Medical Cannabis Market Attractiveness Analysis
13.8.1. By Derivative
13.8.2. By Application
13.8.3. By Route of Administration
13.8.4. By Distribution Channel
13.8.5. By Country/Sub-region
14. Latin America Medical Cannabis Market Analysis
14.1. Latin America Medical Cannabis Market
14.2. Latin America Medical Cannabis Market Overview
14.3. Latin America Medical Cannabis Market Value and Forecast, by Derivative
14.3.1. Tetrahydrocannabinol (THC)
14.3.2. Cannabidiol (CBD)
14.3.3. Others
14.4. Latin America Medical Cannabis Market Value and Forecast, by Application
14.4.1. Mental Health Management
14.4.1.1. Anxiety
14.4.1.2. Depression
14.4.1.3. Others
14.4.2. Neurological Disorders Management
14.4.2.1. Epilepsy
14.4.2.2. Alzheimer’s Disease
14.4.2.3. Parkinson’s Disease
14.4.2.4. Others
14.4.3. Pain Management
14.4.3.1. Neuropathic Pain
14.4.3.2. Cancer Pain
14.4.3.3. Others
14.5. Latin America Medical Cannabis Market Value and Forecast, by Route of Administration
14.5.1. Nasal
14.5.2. Oral
14.5.3. Others
14.6. Latin America Medical Cannabis Market Value and Forecast, by Distribution Channel
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Pharmacies
14.7. Latin America Medical Cannabis Market Forecast, by Country/Sub-region
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Medical Cannabis Market Attractiveness Analysis
14.8.1. By Derivative
14.8.2. By Application
14.8.3. By Route of Administration
14.8.4. By Distribution Channel
14.8.5. By Country/Sub-region
15. Rest of the World Medical Cannabis Market Analysis
15.1. Rest of the World Medical Cannabis Market
15.2. Rest of the World Medical Cannabis Market Overview
15.3. Rest of the World Medical Cannabis Market Value and Forecast, by Derivative
15.3.1. Tetrahydrocannabinol (THC)
15.3.2. Cannabidiol (CBD)
15.3.3. Others
15.4. Rest of the World Medical Cannabis Market Value and Forecast, by Application
15.4.1. Mental Health Management
15.4.1.1. Anxiety
15.4.1.2. Depression
15.4.1.3. Others
15.4.2. Neurological Disorders Management
15.4.2.1. Epilepsy
15.4.2.2. Alzheimer’s Disease
15.4.2.3. Parkinson’s Disease
15.4.2.4. Others
15.4.3. Pain Management
15.4.3.1. Neuropathic Pain
15.4.3.2. Cancer Pain
15.4.3.3. Others
15.5. Rest of the World Medical Cannabis Market Value and Forecast, by Route of Administration
15.5.1. Nasal
15.5.2. Oral
15.5.3. Others
15.6. Rest of the World Medical Cannabis Market Value and Forecast, by Distribution Channel
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Pharmacies
15.7. Rest of the World Medical Cannabis Market Attractiveness Analysis
15.7.1. By Derivative
15.7.2. By Application
15.7.3. By Route of Administration
15.7.4. By Distribution Channel
16. Competitive Landscape
16.1. Company Profiles
16.1.1. Canopy Growth Corporation
16.1.1.1. Overview (HQ, Employee Strength, Business Segments)
16.1.1.2. Financials
16.1.1.3. Recent Developments
16.1.1.4. Strategy
16.1.2. United Cannabis
16.1.2.1. Overview (HQ, Employee Strength, Business Segments)
16.1.2.2. Financials
16.1.2.3. Recent Developments
16.1.2.4. Strategy
16.1.3. Aurora Cannabis
16.1.3.1. Overview (HQ, Employee Strength, Business Segments)
16.1.3.2. Financials
16.1.3.3. Recent Developments
16.1.3.4. Strategy
16.1.4. Cannabis Sativa, Inc.
16.1.4.1. Overview (HQ, Employee Strength, Business Segments)
16.1.4.2. Financials
16.1.4.3. Recent Developments
16.1.4.4. Strategy
16.1.5. Emerald Health Therapeutics
16.1.5.1. Overview (HQ, Employee Strength, Business Segments)
16.1.5.2. Financials
16.1.5.3. Recent Developments
16.1.5.4. Strategy
16.1.6. GW Pharmaceuticals plc.
16.1.6.1. Overview (HQ, Employee Strength, Business Segments)
16.1.6.2. Recent Developments
16.1.6.3. Strategy
16.1.7. Tilray
16.1.7.1. Overview (HQ, Employee Strength, Business Segments)
16.1.7.2. Recent Developments
16.1.7.3. Strategy
16.1.8. Medical Marijuana, Inc.
16.1.8.1. Overview (HQ, Employee Strength, Business Segments)
16.1.8.2. Financials
16.1.8.3. Recent Developments
16.1.8.4. Strategy
16.1.9. The Cronos Group.
16.1.9.1. Overview (HQ, Employee Strength, Business Segments)
16.1.9.2. Financials
16.1.9.3. Recent Developments
16.1.9.4. Strategy
16.1.10. The Supreme Cannabis Company, Inc.
16.1.10.1. Overview (HQ, Employee Strength, Business Segments)
16.1.10.2. Recent Developments
16.1.10.3. Strategy
List of Tables
TABLE 1 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 2 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 3 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 4 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 5 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 6 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 7 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 8 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Region, 2017–2027
TABLE 9 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Country, 2017–2027
TABLE 10 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 11 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 12 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 13 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 14 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 15 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 16 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 17 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 18 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 19 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 20 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 21 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 22 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 23 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 24 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 25 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 26 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 27 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 28 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 29 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 30 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 31 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 32 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 33 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 34 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 35 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 36 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 37 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 38 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 39 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
List of Figures
Figure 1: Global Medical Cannabis Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 2: Global Medical Cannabis Market Value (US$ Mn), by Derivative, 2018
Figure 3: Global Medical Cannabis Market Value Share Analysis by Derivative, 2018
Figure 4: Market Overview
Figure 5: Global Medical Cannabis Market Value (US$ Mn) Forecast, 2017–2027
Figure 6: Global Medical Cannabis Market Value Share, by Derivative, 2018
Figure 7: Global Medical Cannabis Market Value Share, by Application, 2018
Figure 8: Global Medical Cannabis Market Value Share, by Distribution Channel, 2018
Figure 9: Global Medical Cannabis Market Value Share, by Region, 2018
Figure 10: Global Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027
Figure 11: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Tetrahydrocannabinol (THC), 2017–2027
Figure 12: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Cannabidiol (CBD), 2017–2027
Figure 13: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 14: Global Medical Cannabis Market Attractiveness Analysis, by Derivative 2019-2027
Figure 15: Global Medical Cannabis Market Value Share Analysis, by Application, 2018 and 2027
Figure 16: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth, by Mental Health Management, 2017–2027
Figure 17: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth, by Neurological Disorders Management, 2017–2027
Figure 18: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Pain Management, 2017–2027
Figure 19: Global Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027
Figure 20: Global Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 21: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Nasal, 2017–2027
Figure 22: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027
Figure 23: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 24: Global Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 25: Global Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 26: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027
Figure 27: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027
Figure 28: Global Medical Cannabis Market Value (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2027
Figure 29: Global Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 30: Global Medical Cannabis Market Value Share Analysis, by Region, 2018 and 2027
Figure 31: Global Medical Cannabis Market Attractiveness Analysis, by Region, 2019–2027
Figure 32: North America Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 33: North America Medical Cannabis Market Value Share Analysis, by Country, 2018 and 2027
Figure 34: North America Medical Cannabis Market Attractiveness Analysis, by Country, 2019–2027
Figure 35: North America Medical Cannabis Market Value Share, by Derivative, 2018 and 2027
Figure 36: North America Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027
Figure 37: North America Medical Cannabis Market Value Share, by Application, 2018 and 2027
Figure 38: North America Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027
Figure 39: North America Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 40: North America Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 41: North America Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 42: North America Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 43: Europe Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 44: Europe Medical Cannabis Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 45: Europe Medical Cannabis Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 46: Europe Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027
Figure 47: Europe Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027
Figure 48: Europe Medical Cannabis Market Value Share, by Application, 2018 and 2027
Figure 49: Europe Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027
Figure 50: Europe Medical Cannabis Market Value Share, by Route of Administration, 2018 and 2027
Figure 51: Europe Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 52: Europe Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 53: Europe Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 54: Latin America Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 55: Latin America Medical Cannabis Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 56: Latin America Medical Cannabis Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 57: Latin America Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027
Figure 58: Latin America Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027
Figure 59: Latin America Medical Cannabis Market Value Share Analysis, by Application, 2018 and 2027
Figure 60: Latin America Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027
Figure 61: Latin America Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 62: Latin America Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 63: Latin America Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 64: Latin America Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 65: Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 66: Rest of the World Medical Cannabis Market Value Share Analysis, by Derivative, 2018 and 2027
Figure 67: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Derivative, 2018 and 2027
Figure 68: Rest of the World Medical Cannabis Market Value Share Analysis, by Application, 2018 and 2027
Figure 69: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Application, 2019–2027
Figure 70: Rest of the World Medical Cannabis Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 71: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 72: Rest of the World Medical Cannabis Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 73: Rest of the World Medical Cannabis Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 74: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Medical Cannabis Market
*86 figures and 60 tables includes